Skip to search formSkip to main contentSkip to account menu

CEV regimen

Known as: Cytoxan-Etoposide-Vincristine Regimen, VEC regimen 
A regimen consisting of cyclophosphamide, etoposide and vincristine used for the treatment of extensive-stage small cell lung cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Monoclonal antibodies that block the programmed death-1 (anti-PD-1) or cytotoxic T-lymphocyte antigen-4 (CTLA-4) immune… 
2018
2018
671Background: Pexa-Vec is a vaccinia virus engineered to express granulocyte-macrophage colony stimulating factor (GM-CSF… 
Review
2018
Review
2018
ABSTRACT Introduction: Current treatment of advanced melanoma is rapidly changing with the introduction of new and effective… 
Review
2017
Review
2017
Advanced liver cancers and biliary cancers represent diseases with dismal prognosis because of frequent local invasion and… 
Review
2016
Review
2016
The US Food and Drug Administration has been rapidly approving new checkpoint inhibitors and targeted therapies for melanoma and… 
2014
2014
Oncolytic viruses and active immunotherapeutics have complementary mechanisms of action (MOA) that are both self amplifying in… 
2014
2014
The standard vector error correction (VEC) model assumes the iid normal distribution of disturbance term in the model. This paper… 
2013
2013
TPS4161^ Background: Pexa-Vec is a targeted oncolytic and immunotherapeutic vaccinia virus engineered to express human… 
Review
2012
Review
2012
Millions of children each year are exposed to violence in their homes, schools, and communities as both witnesses and victims. As…